NGI during Covid-19 outbreak

NGI is still up and running during the Covid-19 pandemic, but we are experiencing some limitations in terms of personnel and key reagents. Each NGI node is following its respective host university recommendations and will continue operation until further notice.

Read more

Covid-19 grant awarded to NGI

We are thrilled to be awarded funds by SciLifeLab and KAW to develop rapid cDNA and direct RNA sequencing of SARS-CoV-2 using Oxford Nanopore.

We hope to offer this protocol to researchers in the very near future – please get in touch if you’re interested!

Details

8th May 2020

By Phil Ewels

Categories
Keywords